American Society of Hirudotherapy

Unveiling salivary gland-specific gene expression of Piezo1 and Neuroendocrine in the leech Helobdella austinensis

Research article published in Developmental and comparative immunology (2025)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Salivary PharmacologyPyo IH et al. · Developmental and comparative immunology, 2025

Abstract

Mechanotransduction is a critical biological phenomenon in living organisms, with Piezo1 being one of the key mechanotransduction ion channel genes. Piezo1 is widely expressed across various tissues and organs, playing critical roles in numerous biological processes, including innate and adaptive immune activation. While most studies on Neuroendocrine and Piezo functions have focused on vertebrates and higher invertebrates (e.g., Drosophila), however research in lophotrochozoan animal models remains scarce. To address this gap, we utilized Helobdella austinensis (phylum: Annelida) to investigate the putative function of Piezo1 and uncovered evidence related to the neuroendocrine system through spatiotemporal characterization. Our findings represent the developmental contribution of Piezo1 from early to late embryonic stages by demonstrating its expression in a lophotrochozoan. Intriguingly, the expression of Hau-Piezo1 was specifically detected in salivary gland-related precursors and tissues during development. Additionally, Neuroendocrine expression was observed in a lophotrochozoan, suggesting the correlation between neuronal stimulation and immune cells along the salivary glands of leeches. Furthermore, the downregulation of Hau-Piezo1 following bacterial challenge suggests that Piezo1 plays a role in regulating inflammatory responses. Taken together, we characterized the spatiotemporal expression pattern of Hau-Piezo1 in leeches and demonstrated its conserved and diversified functions based on its phylogenetic relationship with other homologs. These results suggest that Piezo1 may serve as a salivary gland marker in leeches and provide evidence for the presence of immune cells along the salivary glands in lophotrochozoans.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsSalivary GlandsIon ChannelsLeechesMechanotransduction, CellularNeurosecretory SystemsPhylogenyGene Expression Regulation, Developmental

Summary

Unveiling salivary gland-specific gene expression of Piezo1 and Neuroendocrine in the leech Helobdella austinensis.

Why This Matters for Hirudotherapy

This study examined the spatiotemporal expression of the mechanotransduction ion channel gene Piezo1 and neuroendocrine markers in the leech Helobdella austinensis. The researchers found that Hau-Piezo1 was specifically detected in salivary gland-related precursors and tissues during development, and its downregulation following bacterial challenge suggests a role in regulating inflammatory responses. For ASH, this is notable because it characterizes potential salivary gland markers in leeches and provides evidence for immune cells along the salivary glands, contributing to basic biological understanding of leech salivary biology. However, this is a developmental biology study in a non-medicinal leech species with no direct therapeutic or clinical data for hirudotherapy.

Citation

Unveiling salivary gland-specific gene expression of Piezo1 and Neuroendocrine in the leech Helobdella austinensis

Pyo IH et al. · Developmental and comparative immunology, 2025

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.